Schedule 13G

Filed by: EAGLE ASSET MANAGEMENT INC
Total Shares: 12,713,061
Subject Company: CTI BioPharma Corp - View Complete Ownership History Backtest
Filed as of Date: 01/07/2015
Event Date: 12/31/2014
Overall % Ownership: 7.2

Reporting Persons

Name Sole
Voting Power
Shared
Voting Power
Sole
Dispositive Power
Shared
Dispositive Power
Aggregate
Amount Owned
Percent
of class
Eagle Asset Management, Inc 592385219 12,713,051 0 12,713,051 0 12,713,061 7.20%
View Original Filing on Edgar's

Raw Filing Contents

0000790502-15-000019.txt : 20150107
0000790502-15-000019.hdr.sgml : 20150107
20150107135935
ACCESSION NUMBER:		0000790502-15-000019
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20150107
DATE AS OF CHANGE:		20150107

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CTI BIOPHARMA CORP
		CENTRAL INDEX KEY:			0000891293
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911533912
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-48459
		FILM NUMBER:		15513052

	BUSINESS ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
		BUSINESS PHONE:		2062827100

	MAIL ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELL THERAPEUTICS INC
		DATE OF NAME CHANGE:	19960321

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EAGLE ASSET MANAGEMENT INC
		CENTRAL INDEX KEY:			0000790502
		IRS NUMBER:				592385219
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		880 CARILLON PARKWAY
		CITY:			ST PETERSBURG
		STATE:			FL
		ZIP:			33716
		BUSINESS PHONE:		7275732453

	MAIL ADDRESS:	
		STREET 1:		880 CARILLON PARKWAY
		CITY:			ST PETERSBURG
		STATE:			FL
		ZIP:			33716
SC 13G 1 CTIC.txt CTI BIOPHARMA CORP.
January 7, 2015 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 RE: Schedule 13G CTI Biopharma Corp. As of December 31, 2014 Gentlemen: In accordance with Section 13(d)(5) of the Securities Exchange Act of 1934, attached please find a copy of Schedule 13G for the above named company showing beneficial ownership of 5% or more as of December 31, 2014 filed on behalf of Eagle Asset Management, Inc. Very truly yours, Damian Sousa Vice President Chief Compliance Officer Enclosures cc: Office of the Corporate Secretary CTI BioPharma Corporation 3101 Western Avenue Suite 600 Seattle WA, 98121 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CTI BIOPHARMA CORP. (Name of Issuer) Common Stock (Title of Class of Securities) 12648L106 (CUSIP Number) Check the following box if a fee is being paid with this statement _____. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages CUSIP NO. 12648L106 13G 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Eagle Asset Management, Inc. 59-2385219 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) ______ (B) ______ 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Florida NUMBER OF 5 SOLE VOTING POWER SHARES 12,713,051 BENEFICIALLY 6 SHARED VOTING POWER OWNED - - - AS OF DECEMBER 31, 2014 7 SOLE DISPOSITIVE POWER BY EACH 12,713,051 REPORTING 8 SHARED DISPOSITIVE POWER PERSON WITH - - - 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,713,051 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_____] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.20% 12 TYPE OF REPORTING PERSON* IA _____________________________________________________________ *SEE INSTRUCTION BEFORE FILLING OUT! _____________________________________________________________ Page 2 of 5 Pages Item 1(a) Name of Issuer: CTI BIOPHARMA CORP. Item 1(b) Address of Issuer's Principal Executing Offices: 3101 Western Avenue Suite 600 Seattle, WA 98121 Item 2(a) Name of Person Filing: Eagle Asset Management, Inc. Item 2(b) Address of Principal Business Office: 880 Carillon Parkway St. Petersburg, Florida 33716 Item 2(c) Citizenship: Florida Item 2(d) Title of Class of Securities: Common Stock Item 2(e) CUSIP Number: 12648L106 Item 3 Type of Reporting Person: (e) Investment Adviser registered under Section 203 of the Investment Advisors Act of 1940 Page 3 of 5 Pages Item 4 Ownership as of December 31, 2014 (a) Amount Beneficially Owned: 12,713,051 shares of common stock beneficially owned including: No. of Shares Eagle Asset Management, Inc. 12,713,051 (b) Percent of Class: 7.20% (c) Deemed Voting Power and Disposition Power: (i) (ii) (iii) (iv) Deemed Deemed Deemed Deemed to have to have to have to have Sole Power Shared Power Sole Power Shared Power to Dispose to Dispose to Vote or to Vote or or to or to to Direct to Direct Direct the Direct the to Vote to Vote Disposition Disposition Eagle Asset 12,713,051 ---- 12,713,051 ---- Management, Inc. Item 5 Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. (___) Item 6 Ownership of More than Five Percent on Behalf of Another Person: N/A Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company: N/A Page 4 of 5 Pages Item 8 Identification and Classification of Members of the Group: N/A Item 9 Notice of Dissolution of Group: N/A Item 10 Certification: By signing below I certify that to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 7, 2015 EAGLE ASSET MANAGEMENT, INC. /s/ Damian Sousa _________________________________ Damian Sousa Vice President Chief Compliance Officer Page 5 of 5 Pages
WhaleWisdom Logo

Elevate your investments